Portman Statement on China’s Announcement on Fentanyl

April 1, 2019 | Press Releases

WASHINGTON, D.C. – U.S. Senator Rob Portman (R-OH) issued the following statement on news reports that China said it will begin regulating all fentanyl-related drugs as a class of controlled substances: 

“I am pleased to see news reports that China announced it will place fentanyl-related substances on its list of controlled substances.  This could be a powerful first step towards limiting fentanyl-related deaths here in the United States, but we must monitor closely how China implements and enforces these new restrictions.  Congress enacted the STOP Act last year to help stop the influx of fentanyl into the U.S. from China, and that legislation is now being implemented.  As part of that process, China must also step up to provide the U.S. Postal Service advanced electronic data so U.S. Customs and Border Protection can target, track, screen, and interdict packages suspected of containing illegal drugs.” 

NOTE: Senator Portman has led efforts in the Senate to reduce the supply of cheap, deadly synthetic drugs like fentanyl, much of which has been coming into the United States from China.  In November, President Trump signed into law an opioids package that included Portman’s Synthetics Trafficking & Overdose Prevention (STOP) Act.  The measure is designed to help reduce the supply of fentanyl that is shipped into the U.S. through the Postal Service.  The Permanent Subcommittee on Investigations (PSI), which Portman chairs, conducted an 18-month investigation into this issue and released a shocking bipartisan report detailing how drug traffickers exploit vulnerabilities in our international mail system to easily ship synthetic drugs like fentanyl from China into the United States through the U.S. Postal Service. The STOP Act closes the loophole.